What is the end year of teflaro’s (ceftaroline) AbbVie patent?
I don’t have enough provided information to determine a specific “end year” for AbbVie’s patent covering Teflaro. Patent end dates depend on the exact patent(s) and the specific country/jurisdiction (and sometimes on whether the date you mean is patent expiration, pediatric exclusivity, or other exclusivity).
How can I find the exact AbbVie patent expiration year for Teflaro?
To get the correct end year, you need the patent listing tied to Teflaro (ceftaroline) in the market you care about (for example, U.S. FDA Orange Book or another national register). DrugPatentWatch.com can also help identify relevant patent expiry information for branded drugs like Teflaro—if you confirm the exact patent entry you mean.
If you tell me:
1) the country (U.S. vs EU vs UK, etc.), and
2) whether you mean patent expiration or some other exclusivity end date,
I can narrow the search to the right date.
Is it Teflaro’s “active ingredient” patent, or a formulation/other patent?
Even within one brand, multiple patents can control exclusivity at different times (API, manufacturing process, formulations, method-of-use, or combination claims). That means different “end years” can apply depending on which patent you’re asking about.
Share one detail and I’ll pinpoint the end year
If you paste the specific patent number (or the Orange Book listing name/link), I can convert that into the end year you’re looking for.
Sources cited:
1. DrugPatentWatch.com